English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Our Next CML Regional Discussion Group: South Asia
Following on from the trio of successful Regional Discussion Groups for Latin American physicians, we’re pleased to introduce to you our next regionally specific, zoom-based Regional Discussion Groups supporting CML physicians in South Asia. The first discussion will take place on July 26th.
CML Highlights of EHA 2023 on July 12th at 2pm CEST
June 2023 - The recent European Hematology Association Congress in Frankfurt has just come to an end, and we are pleased to bring you CML highlights fresh from the meeting.
Our ‘CML Highlights of EHA’ webinar will take place on Wednesday, July 12th at 2pm Central European Summer Time on Zoom as part of our series of iCMLf Conversations.
Our two experts Professor Andreas Hochhaus (Germany) and Professor S. Tiong Ong (Singapore) will discuss significant clinical and biological aspects of the CML data presented during the meeting.
Don’t miss this opportunity and join us for the live webinar.
Getting ready for the EHA Congress - Overview of CML sessions
May 2022 - There are only a few weeks to go until the 2023 Congress of the European Hematology Association (EHA). The congress will be held as a hybrid meeting in Frankfurt:
- June 8-11: Live streamed program
- June 14-15: Virtual days
To help you plan your CML meeting schedule at EHA we have compiled a list of CML related sessions for your convenience.
Send us your questions on TKI toxicities & dose optimisation in CML - Live Q&A session on May 31st
May 2022 - Our ‘Meet-the-CML-Experts’ live Q&A Session this year is getting closer.
And we hope to see you there!
During this 45-min Q&A session on May 31st at 2 pm CEST, you will have the chance to ask all your questions on managing safety issues and strategies for dose optimisation to our panel of CML experts; Professor Jeff Lipton and Professor Gianantonio Rosti.
Take the chance to get a first-hand expert opinion to help your clinical practice.
Get in first and submit your questions now!
Mee-the-Expert Q&A Session: TKI Toxicities and Dose Optimisation in CML
Save-the-date: May 31st, 2023 at 2 pm Central European Summer Time
April 2023 - After last year’s great success, we will host another Meet-the-CML-Experts Q&A session in May. Save 2pm CEST May 31st to your calendar for this iCMLf Conversation and submit your questions and cases.
Professors Jeff Lipton (Canada) and Gianantonio Rosti (Italy) will be available as our panel of CML experts for a 45-minute live Q&A session.
This time, we will focus on two topics that are highly relevant for your clinical practice:
- Managing safety issues and TKI toxicities
- Strategies for dose optimisation
You can submit your questions and cases even before the meeting through our survey to come or by emailing info@cml-foundation.org.
Recognising those improving CML treatment in Low and Middle Income Countries - the 2023 iCMLf Prize nominees
April 2023 - The iCMLf Prize honours people who have done outstanding work improving CML management under resource-constraint conditions in low and middle-income countries. Each year, we receive many nominations from the CML community for this prize…
And it’s always difficult to make a choice...
This year the iCMLf prize was awarded to Professor Iryna Dyagil and Dr Kostyantyn Kotlyarchuk, two Ukrainian hematologists in recognition of their work for people with CML under the challenging conditions of war and disruption.
In addition, there were also 11 physicians and patient advocates from ten different countries who were nominated for their dedication and life changing work for people with CML.
Today we are taking the opportunity to acknowledge all of the nominees and to thank them for their work to help people with CML in low and middle-income countries – through their research, their clinical practice and through their advocacy.
